Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.

Barratt A.

BMJ. 2015 Mar 3;350:h867. doi: 10.1136/bmj.h867. No abstract available.

PMID:
25736426
2.

StatBite: Percent change in DCIS, invasive breast cancer, and mammography.

[No authors listed]

J Natl Cancer Inst. 2011 Mar 16;103(6):457. doi: 10.1093/jnci/djr084. Epub 2011 Mar 10. No abstract available.

PMID:
21393608
3.

Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.

Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Jan;50(1):185-92. doi: 10.1016/j.ejca.2013.08.013. Epub 2013 Sep 13.

4.

Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.

Román M, Rué M, Sala M, Ascunce N, Baré M, Baroja A, De la Vega M, Galcerán J, Natal C, Salas D, Sánchez-Jacob M, Zubizarreta R, Castells X; Cumulative False Positive Risk Group.

PLoS One. 2013 Dec 23;8(12):e83121. doi: 10.1371/journal.pone.0083121. eCollection 2013.

5.

Screening for early breast cancer reduces invasive cancer, study finds.

Mayor S.

BMJ. 2015 Dec 6;351:h6576. doi: 10.1136/bmj.h6576. No abstract available.

PMID:
26643040
6.

Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.

Coldman A, Phillips N.

CMAJ. 2013 Jul 9;185(10):E492-8. doi: 10.1503/cmaj.121791. Epub 2013 Jun 10.

7.

Detection of ductal carcinoma in situ and subsequent interval cancers.

Shieh Y, Eklund M, Esserman L.

BMJ. 2016 Feb 1;352:i551. doi: 10.1136/bmj.i551. No abstract available.

PMID:
26834245
8.

Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk.

Iwase M, Tsunoda H, Nakayama K, Morishita E, Hayashi N, Suzuki K, Yamauchi H.

Breast Cancer. 2017 Jul;24(4):579-584. doi: 10.1007/s12282-016-0742-z. Epub 2016 Nov 21.

PMID:
27873170
9.

Persistent Untreated Screening-Detected Breast Cancer: An Argument Against Delaying Screening or Increasing the Interval Between Screenings.

Arleo EK, Monticciolo DL, Monsees B, McGinty G, Sickles EA.

J Am Coll Radiol. 2017 Jul;14(7):863-867. doi: 10.1016/j.jacr.2017.01.038. Epub 2017 Apr 28.

PMID:
28457814
10.

Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.

Lee L, Pintilie M, Hodgson DC, Goss PE, Crump M.

Ann Oncol. 2008 Jan;19(1):62-7. Epub 2007 Sep 17.

PMID:
17878177
11.

DCIS and invasive interval breast cancer.

Foucar E.

Lancet Oncol. 2016 Mar;17(3):e87. doi: 10.1016/S1470-2045(15)00624-5. Epub 2016 Mar 2. No abstract available.

PMID:
26972860
12.

DCIS and invasive interval breast cancer.

Narod SA, Sopik V, Sun P.

Lancet Oncol. 2016 Mar;17(3):e87-8. doi: 10.1016/S1470-2045(16)00023-1. Epub 2016 Mar 2. No abstract available.

PMID:
26972859
13.

Detection of DCIS and reduced invasive interval cancers.

Evans A.

Lancet Oncol. 2016 Jan;17(1):14-5. doi: 10.1016/S1470-2045(15)00481-7. Epub 2015 Dec 5. No abstract available.

14.

DCIS and invasive interval breast cancer - Author's reply.

Duffy SW.

Lancet Oncol. 2016 Mar;17(3):e88-9. doi: 10.1016/S1470-2045(16)00104-2. Epub 2016 Mar 2. No abstract available.

PMID:
26972861
15.

Optimizing Mammography Screening Intervals.

Yi M, Hunt KK.

JAMA. 2015 Oct 20;314(15):1635-6. doi: 10.1001/jama.2015.13149. No abstract available.

PMID:
26501538
16.

Screening mammography after autologous breast reconstruction is not beneficial.

Barton MK.

CA Cancer J Clin. 2015 Jan-Feb;65(1):3-4. doi: 10.3322/caac.21256. Epub 2014 Dec 22. No abstract available.

17.

Mode of detection and secular time for ductal carcinoma in situ.

Pisano ED.

J Natl Cancer Inst Monogr. 2010;2010(41):142-4. doi: 10.1093/jncimonographs/lgq028. Review.

18.

Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.

Heinävaara S, Sarkeala T, Anttila A.

Br J Cancer. 2014 Sep 23;111(7):1463-8. doi: 10.1038/bjc.2014.413. Epub 2014 Aug 14.

19.

[Audit system on quality of breast cancer diagnosis and treatment: results of quality indicators on screen-detected lesions in Italy, 2010].

Ponti A, Mano MP, Tomatis M, Baiocchi D, Barca A, Berti R, Bisanti L, Casella D, Deandrea S, Delrio D, Donati G, Falcini F, Frammartino B, Frigerio A, Mantellini P, Naldoni C, Orzalesi L, Pagano G, Pietribiasi F, Ravaioli A, Sedda ML, Taffurelli M, Cataliotti L, Segnan N.

Epidemiol Prev. 2012 Nov-Dec;36(6 Suppl 1):87-95. Italian.

20.

Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.

Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, Tuttobene P, Bricolo P, Fantò C, Valentini M, Montemezzi S, Macaskill P.

Lancet Oncol. 2013 Jun;14(7):583-9. doi: 10.1016/S1470-2045(13)70134-7. Epub 2013 Apr 25.

PMID:
23623721

Supplemental Content

Support Center